Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07265284
What this trial is testing

Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 104
Testing effectiveness (Phase 2)Study completedNCT03010527
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 217
Early research (Phase 1)Study completedNCT02156466
What this trial is testing

Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects

Who this might be right for
Psoriasis
Merck KGaA, Darmstadt, Germany 41
Not applicableStudy completedNCT00678470
What this trial is testing

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Psoriasis
University of California, San Francisco 18
Early research (Phase 1)Ended earlyNCT01948271
What this trial is testing

Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 3
Large-scale testing (Phase 3)Study completedNCT01412944
What this trial is testing

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 43
Not applicableLooking for participantsNCT07039110
What this trial is testing

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
AbbVie 700
Large-scale testing (Phase 3)Study completedNCT06011733
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 133
Testing effectiveness (Phase 2)Study completedNCT01230138
What this trial is testing

Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH 252
Large-scale testing (Phase 3)Study completedNCT03255382
What this trial is testing

Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic Therapy

Who this might be right for
Psoriasis
AbbVie 120
Testing effectiveness (Phase 2)Study completedNCT00852670
What this trial is testing

ACT-128800 in Psoriasis

Who this might be right for
Plaque Psoriasis
Actelion 66
Testing effectiveness (Phase 2)Study completedNCT02899988
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 205
Large-scale testing (Phase 3)Active Not RecruitingNCT06630559
What this trial is testing

Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis

Who this might be right for
Plaque Psoriasis
Celltrion 153
Large-scale testing (Phase 3)WithdrawnNCT01900782
What this trial is testing

Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00646191
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 137
Large-scale testing (Phase 3)Study completedNCT01815424
What this trial is testing

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 266
Large-scale testing (Phase 3)Study completedNCT03701763
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 245
Large-scale testing (Phase 3)Active Not RecruitingNCT06611163
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Who this might be right for
Moderate to Severe Genital Psoriasis
Sun Pharmaceutical Industries Limited 206
Testing effectiveness (Phase 2)Study completedNCT05600036
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 228
Large-scale testing (Phase 3)Study completedNCT00237887
What this trial is testing

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 1,212
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation